Locations:
Search
Risk is not trivial; finding may assist in informed decision making
New research demonstrates that cfDNA methylation patterns may noninvasively identify tumor hypoxia in head and neck squamous cell carcinoma
Program reduces major contour changes and variations in organ-at-risk dosing across health system
No significant differences seen in breast volume loss between whole and partial breast treatment approaches
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Despite wide variations in contours, researchers find AI and physician methods yield equivalent results.
New system refines classification of cytogenetic abnormalities at time of response assessment and their clinical significance
Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness
Questions remain about the merits of asparaginase-based therapy
Radiation therapy produces anti-inflammatory response
Phase 1 study found mutant calreticulin-specific monoclonal antibody brings promising results with no dose-limiting toxicities
Advertisement
Advertisement